132 related articles for article (PubMed ID: 20669154)
1. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
[TBL] [Abstract][Full Text] [Related]
2. Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.
Gentile M; Mauro FR; Rossi D; Vincelli I; Tripepi G; Recchia AG; De Stefano L; Campanelli M; Giannarelli D; Bossio S; Morabito L; Vigna E; Gaidano G; Foà R; Morabito F
Br J Haematol; 2014 Oct; 167(2):224-32. PubMed ID: 25041609
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
4. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP
Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for terminally ill cancer patients.
Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
[TBL] [Abstract][Full Text] [Related]
6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
7. External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia.
Molica S; Giannarelli D; Gentile M; Cutrona G; Di Renzo N; Di Raimondo F; Neri A; Federico M; Ferrrarini M; Morabito F
Cancer; 2013 Mar; 119(6):1177-85. PubMed ID: 23224939
[TBL] [Abstract][Full Text] [Related]
8. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
9. A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.
Lee CK; Hudson M; Stockler M; Coates AS; Ackland S; Gebski V; Lord S; Friedlander M; Boyle F; Simes RJ
Breast Cancer Res Treat; 2011 Sep; 129(2):467-76. PubMed ID: 21445568
[TBL] [Abstract][Full Text] [Related]
10. CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.
Hock BD; McKenzie JL; McArthur L; Tansley S; Taylor KG; Fernyhough LJ
Intern Med J; 2010 Dec; 40(12):842-9. PubMed ID: 20002855
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
Delgado J; Pratt G; Phillips N; Briones J; Fegan C; Nomdedeu J; Pepper C; Aventin A; Ayats R; Brunet S; Martino R; Valcarcel D; Milligan D; Sierra J
Br J Haematol; 2009 Jun; 145(6):801-5. PubMed ID: 19388937
[TBL] [Abstract][Full Text] [Related]
12. A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.
D'Arena G; D'Auria F; Simeon V; Laurenti L; Deaglio S; Mansueto G; Del Principe MI; Statuto T; Pietrantuono G; Guariglia R; Innocenti I; Martorelli MC; Villani O; De Feo V; Del Poeta G; Musto P
Am J Hematol; 2012 Jun; 87(6):628-31. PubMed ID: 22460620
[TBL] [Abstract][Full Text] [Related]
13. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
14. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].
Lü JM; Liang J; Wang JW; He J; Xiao ZF; Zhang HX; Chen DF; Feng QF; Wang LH
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):121-5. PubMed ID: 19538888
[TBL] [Abstract][Full Text] [Related]
16. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
20. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
